{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:53:00Z","timestamp":1769115180842,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ijcha.2021.100871","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T02:49:25Z","timestamp":1631587765000},"page":"100871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"36","author":[{"given":"Naser","family":"Yamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gosain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaneez","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Tariq","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humera","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izza","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sameer","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal","family":"Almas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcha.2021.100871_b0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.15420\/cfr.2019.9.2","article-title":"Why is iron deficiency recognised as an important comorbidity in heart failure?","volume":"5","author":"Ebner","year":"2019","journal-title":"Card. Fail. Rev."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100871_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2021.100871_b0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2021.100871_b0020","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","article-title":"Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status","volume":"15","author":"Comin-Colet","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2021.100871_b0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J. Card Fail."},{"key":"10.1016\/j.ijcha.2021.100871_b0030","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2021.100871_b0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2019.02.018","article-title":"Iron supplementation improves cardiovascular outcomes in patients with heart failure","volume":"132","author":"Zhou","year":"2019","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100871_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcha.2021.100871_b0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"27","key":"10.1016\/j.ijcha.2021.100871_b0050","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100871_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.ijcha.2021.100871_b0060","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2021.100871_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre randomised, controlled, double-blind trial","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ijcha.2021.100871_b0070","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2021.100871_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.ijcha.2021.100871_b0080","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ijcha.2021.100871_b0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synthesis Methods"},{"key":"10.1016\/j.ijcha.2021.100871_b0090","doi-asserted-by":"crossref","unstructured":"Addressing Reporting Biases. Cochrane Handbook for Systematic Reviews of Interventions, 2008, pp. 297\u2013333.","DOI":"10.1002\/9780470712184.ch10"},{"issue":"7414","key":"10.1016\/j.ijcha.2021.100871_b0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.ijcha.2021.100871_b0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100871_b0105","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100871_b0110","article-title":"The safety of intravenous (IV) ferric carboxymaltose versus IV iron sucrose in patients with chronic heart failure (CHF) and chronic kidney disease (CKD) with iron deficiency (ID)","volume":"8","author":"Arutyunov","year":"2009","journal-title":"Eur. J. Heart Fail. Suppl."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100871_b0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amjcard.2018.04.062","article-title":"Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure","volume":"122","author":"McCullough","year":"2018","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100871_b0120","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int J Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100871_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail. Rev."},{"issue":"12","key":"10.1016\/j.ijcha.2021.100871_b0130","first-page":"e004873","article-title":"National Burden of Heart Failure Events in the United States, 2006 to 2014","volume":"11","author":"Jackson","year":"2018","journal-title":"Circulation: Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100871_b0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ehf2.12021","article-title":"Improving care for patients with acute heart failure: before, during and after hospitalization","volume":"1","author":"Cowie","year":"2014","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcha.2021.100871_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/j.1540-8167.2002.tb01954.x","article-title":"Current limitations in treatment of heart failure: New avenues and treatment options","author":"Drexler","year":"2002","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100871_b0145","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/CIRCULATIONAHA.117.032099","article-title":"Glucose-lowering therapies and heart failure in type 2 diabetes mellitus: mechanistic links, clinical data, and future directions","volume":"137","author":"Vijayakumar","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcha.2021.100871_b0150","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jchf.2020.05.011","article-title":"The maximally tolerated dose: the key context for interpreting subtarget medication dosing for heart failure","volume":"8","author":"Greene","year":"2020","journal-title":"JACC Heart Fail."},{"issue":"19","key":"10.1016\/j.ijcha.2021.100871_b0155","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8 Suppl","key":"10.1016\/j.ijcha.2021.100871_b0160","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.cardfail.2019.07.399","article-title":"Outcome of titrating guideline directed medical therapy in heart failure patients at 90-day post-hospital discharge","volume":"25","author":"Eivazi","year":"2019","journal-title":"J. Cardiac Fail."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100871_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCOUTCOMES.110.959122","article-title":"Get with the Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure","volume":"5","author":"Heidenreich","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"1","key":"10.1016\/j.ijcha.2021.100871_b0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2021.100871_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-7-3","article-title":"Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients","volume":"7","author":"Luthi","year":"2006","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ijcha.2021.100871_b0180","first-page":"22B","article-title":"Chronic kidney disease, heart failure and anemia","volume":"24","author":"Virani","year":"2008","journal-title":"Can. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100871_b0185","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00467-006-0405-y","article-title":"Iron therapy for renal anemia: how much needed, how much harmful?","volume":"22","author":"H\u00f6rl","year":"2007","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100871_b0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00228-019-02813-y","article-title":"Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF-PH inhibitor for the treatment of renal anaemia","volume":"76","author":"Lentini","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"21","key":"10.1016\/j.ijcha.2021.100871_b0195","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2021.100871_b0200","doi-asserted-by":"crossref","unstructured":"Comin-Colet J., Lainscak M., Dickstein K., Filippatos G.S., Johnson P., L\u00fcscher T.F., Mori C., Willenheimer R., Ponikowski P., Anker S.D., The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: A subanalysis of the FAIR-HF study. (2013).","DOI":"10.1093\/eurheartj\/ehr504"},{"issue":"15","key":"10.1016\/j.ijcha.2021.100871_b0205","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ijcha.2021.100871_b0210","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"NHLBI heart failure clinical research network. effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:09:42Z","timestamp":1762492182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906721001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S2352906721001597"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100871","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100871"}}